Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...

For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma ...

More information is available at www.Yaqrit.com In over 10 million patients worldwide per year, liver cirrhosis progresses from an asymptomatic (compensated) form to the decompensated form at which ...

A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) ...

In addition, the 15-year cumulative incidence of progression to decompensated cirrhosis was 15.6% in the surgical group and 30.7% in the nonsurgical group (aHR, 0.2; P = .01), with decompensation ...

Heavy alcohol use is taking an earlier toll, landing more young Americans onto transplant lists. The obesity epidemic makes ...

The analysis included 16,501 participants: 3610 statin users and 12,891 nonusers. HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for ...

The secondary composite endpoint was progression from compensated to decompensated cirrhosis. Mean follow-up was 10 ± 4.5 years, including 10.1 ± 3.7 years in the surgical group and 9.9 ± 5.1 ...

A recent study found metabolic surgery to demonstrate significant benefits in lowering the risk of major adverse liver outcomes (MALO) for cirrhosis patients due to metabolic ...